The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy). The ...

According to the FDA, the benefits of vaccination with Abrysvo and Arexvy continue to outweigh the potential risks. The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine ...

After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s groundbreaking vaccines made waves as the first immunizations against the common respiratory illness. Now, health ...

Group B Streptococcus, which people may call group B strep (GBS), is a type of bacterium that causes GBS disease. GBS can lead to meningitis, which is an infection of the lining of the brain and ...

Ali Sudderth, a 33-year-old woman said that she woke up with "tingly" toes and slowly her entire body became numb and she ...

Analysis of blood samples from 42 patients diagnosed with Guillain-Barré syndrome (GBS) during the Zika virus outbreak in French Polynesia provides the first evidence that Zika virus might cause GBS, ...

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for ...

Group B Strep (GBS) is just one of the many bacterial communities that colonize a healthy adult. GBS bacteria live harmlessly in approximately 25 percent of healthy women. However, when the bacteria ...

Researchers have discovered how the bacteria Group B streptococcus (GBS) avoids detection by the immune system during pregnancy. The findings, reported in the journal mBio, could lead to the ...

A new study could explain why some mothers can still pass Group B Streptococcus, or GBS, to their babies after childbirth even when they're treated ...